Koneksa Health Revenue and Competitors

Location

#280

Growjo Ranking

Research

Industry

Estimated Revenue & Valuation

  • Koneksa Health's estimated annual revenue is currently $11.3M per year.(i)
  • Koneksa Health's estimated revenue per employee is $102,000
  • Koneksa Health's total funding is $70.6M.

Employee Data

  • Koneksa Health has 111 Employees.(i)
  • Koneksa Health grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1760M735219%$7M$34.4B
Add Company

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.

keywords:Pharmaceuticals, Health Care Information Technology, Deep Information Technology, Technology, Clinical Trials, Contract Research Organizations

$70.6M

Total Funding

111

Number of Employees

$11.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Koneksa Health News

2022-04-06 - Digital Biomarkers Global Markets Research Report 2022 ...

Pharmaceutical Companies and Research Institutions; Healthcare Providers; Payers ... Ixico plc; Koneksa; Mindstrong Health; Winterlight Labs.

2022-02-22 - Koneksa lands new round of funds to develop app-based digital ...

The team at Koneksa Health is developing that possibility right now, and on Monday, announced a $45 million Series C financing round to...

2020-09-29 - Koneksa Closes $16M Series B Financing

Koneksa, a NYC-based developer of patient-centric digital biomarkers for drug development, closed a $16M Series B financing round. The round was led by Spring Mountain Capital with participation from McKesson Ventures, Novartis Pharma AG and MBX Capital and existing investors Merck Global Healt ...

2020-09-28 - Koneksa Raises $16M Series B

Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, announced today the completion of a $16M Series B financing round. The company plans to use the investment to expand the development of its digital platform for integrating wearables, sens ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30M11152%N/A
#2
$30M1114%N/A
#3
$24.4M11126%N/A
#4
$16.1M11152%N/A
#5
$16.1M111N/AN/A